Frontiers | Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators | Pharmacology
JCM | Free Full-Text | Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine | HTML
Cystic fibrosis in the year 2020: A disease with a new face - De Boeck - 2020 - Acta Paediatrica - Wiley Online Library
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives | Journal of Medicinal Chemistry
Lumacaftor - an overview | ScienceDirect Topics
iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation - ScienceDirect
Lumacaftor/ivacaftor - Wikipedia
The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway | Scientific Reports
The structures of lumacaftor and ivacaftor. Lumacaftor is a cystic... | Download Scientific Diagram
Lumacaftor - an overview | ScienceDirect Topics
Stopcriteria CFTR-modulatoren bij CF - Richtlijn - Richtlijnendatabase
Frontiers | Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine | Pharmacology
Mechanism of Action | ORKAMBI® (lumacaftor/ivacaftor)
Frontiers | CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy | Molecular Biosciences
PDF) Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
PDF) Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Profile of lumacaftor/ivacaftor combination: potential in the treatmen | ODRR
Frontiers | Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators | Pharmacology
CFTR: New insights into structure and function and implications for modulation by small molecules - Journal of Cystic Fibrosis
Progress in therapies for cystic fibrosis - The Lancet Respiratory Medicine
Stopcriteria CFTR-modulatoren bij CF - Richtlijn - Richtlijnendatabase
Frontiers | Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators | Pharmacology
How ORKAMBI® (lumacaftor/ivacaftor) Works | Watch the Video
Stopcriteria CFTR-modulatoren bij CF - Richtlijn - Richtlijnendatabase
